Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study (Q37558832)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study |
scientific article |
Statements
1 reference
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study (English)
1 reference
Philipp von Rosenstiel
1 reference
Ludwig Kappos
1 reference
Giancarlo Comi
1 reference
Jacqueline Palace
1 reference
Ralf Gold
1 reference
Mahendra Bijarnia
1 reference
Rebecca Gottschalk
1 reference
Davorka Tomic
1 reference
Arno Siever
1 reference
FIRST Study Investigators
1 reference
1 reference
13 November 2013
1 reference
Identifiers
1 reference